Bacteria have been in existence for at least 3.5 billion years \[[@R1]\] and, until multicellular eukaryotes appeared \~1 billion years ago, were essentially free-living organisms. The advent of multicellar organisms provided a new environmental niche in which bacteria have continued to coevolve with their larger counterparts. Prokaryotes can be free-living, commensal (do no harm), symbiotic (do good), opportunistic pathogens (do harm, but only in compromised hosts), and frank pathogens (do harm in healthy as well as compromised hosts). In addition, pathogenic bacteria may be only briefly associated with the host, establish long-term infections, or require the host for survival (obligate pathogens). This relationship is continually evolving (toward or away from pathogenicity or host dependence), with the adaptation of both the bacterium and the host. This process is continuing today, as much as in any time during evolution.

Bacteria of the genus *Borrelia*are host-dependent spirochetes that are reliant on continual transmission between vertebrate hosts (most commonly mammals and birds) and arthropod vectors (ticks and lice). The genus bifurcated into two forms that cause Lyme borreliosis (LB) and relapsing fever (RF) millions of years ago (based on genetic evidence), but these groups are still quite closely related. LB spirochetes are transmitted by slow-feeding, hard-bodied ticks of the genus *Ixodes*. The many species that cause endemic RF are predominantly carried by fast-feeding, soft-bodied *Ornithodoros* ticks, whereas *B. recurrentis*, the causative agent of epidemic RF, is passed between humans by the human body louse, *Pediculus humanus* subsp. *humanus*. Of the 10 species and 2 proposed species of LB spirochetes, *B. burgdorferi, B. garinii*, and *B. afzelii* commonly cause Lyme disease in Eurasia, but only *B. burgdorferi*is known to cause human disease in North America. Following transmission, LB infections typically have an indolent course with loosely defined localized, disseminated, and persistent stages; symptoms can persist over a period of months to years if untreated. This pattern thus has some similarity to infection with another invasive, persistent spirochetal pathogen, *Treponema pallidum*, which causes the sexually transmitted disease syphilis (Fig. **[1](#F1){ref-type="fig"}**). In contrast, the course of RF is typified by short, 3-day, recurrences of high level bacteremia (up to 10^8^ bacteria/ml of blood) with high fever and other constitutional symptoms. No toxins have been identified for *Borrelia*species or *T. pallidum*, and it is thought that the manifestations of their corresponding diseases are due primarily to their ability to invade and propagate within the host and to stimulate of host inflammatory reactions.

One of the main projects in our laboratory is the global identification and characterization of virulence determinants in *B. burgdorferi*. Virulence determinants represent a broader category than virulence factors. Virulence determinants include any gene product that enhances the ability of the organism to cause disease, e.g. metabolic pathways that are required for the survival and growth of the pathogen in the host. Virulence factors are more narrowly defined as bacterial products that are specifically involved in the pathogenic properties of the organism. Examples of virulence factors include adhesins, toxins, and degradative enzymes involved in tissue invasion, as well as protective activities against the immune system such as capsules, antigenic variation systems, and antibody or complement inactivation mechanisms. Because LB spirochetes produce no known toxins, it is not possible to simply purify a protein and demonstrate that it has a lytic or cytopathic activity. Instead, the screening for genes and gene products that play a role in infectivity and pathogenesis typically requires the whole organism; exceptions are adhesins, which can be identified ex vivo by their binding to host cells or extracellular matrix (ECM) components \[[@R2]\].

The system that we have chosen for virulence determinant analysis is transposon mutagenesis with the addition of DNA sequence 'tags', a technique called signature tag mutagenesis (STM) \[[@R3]\]. In our studies, we have utilized derivatives of the *Mariner*transposon vector called pGKT, which was developed by Dr. Philip Stewart specifically for use in LB organisms \[[@R4]\]. *Mariner* transposons insert in DNA at any occurrence of the dinucleotide TA, resulting in a library of transposon insertions that are randomly located throughout the genome. Dr. Tao Lin in our laboratory added 11 different 7-basepair 'tags' into pGKT, permitting the identification of individual clones in a mixture. The bacterial strain we utilized is *B. burgdorferi* B31 5A18NP1, which was derived by Dr. Hiroki Kawabata to provide an infectious yet moderately transformable LB strain \[[@R5]\]. By electroporating the pGK derivatives into 5A18NP1, we isolated 4,479 *B. burgdorferi*mutants in which the specific insertion sites and the plasmid content \[[@R6]\] were both determined. Analyzing the plasmid content was important, because this strain of *B. burgdorferi* has 19 plasmids. Most of these can be lost during *in vitro* culture, and at least three are required for full infectivity in mammals \[[@R7]-[@R10]\]. By identifying the insertion site of each transposon mutant, we were able to identify the genes that were inactivated by this insertion. This so-called 'ordered' library has two advantages. First, it permits the identification of nonessential genes, i.e. those that are not required for the growth of *B. burgdorferi* in the Barbour-Stoenner-Kelly medium that is standardly used for culturing *Borrelia* strains. Second, it allows the systematic examination of genes that may be involved in infectivity. To determine the infectivity of these mutants while minimizing the number of animals needed, we have inoculated mice with groups of 11 5A18NP1 transposon mutants, each marked with a different signature tag. After the mice have be infected for either 2 or 4 weeks, bladder, ear, heart, joint, and inoculation site tissue samples are obtained and subjected to a novel Luminex-based method that uses PCR of the signature tag region to specifically identify each of the 11 clones. Low median fluorescence intensity (MFI) values for a particular clone means that the gene disrupted by the transposon is required for infection or dissemination in the mouse model. An example of one of these experiments is shown in Fig. (**[2](#F2){ref-type="fig"}**). For each time point, the MFI values obtained in 5 tissues in each of 3 mice are stacked to indicate the cumulative MFI value. The first two clones (with disruptions in the nicotinamidase gene *pncA* and the hypothetical protein gene *BB0051*, respectively) serve as negative and positive controls. Mutations in *malX*, *bba06*, *bb0021*, and *truB* yielded consistently low values, indicating loss of infectivity. *sodA*and *erpA* mutants yielded intermediate values, whereas *rev*, *gidB*, and *recG* mutants exhibited high levels on infection. The results from these studies thus serve as a screening method for determining which genes are most important in mammalian infection.

A second area of study in our laboratory is the *vls*antigenic variation systems of LB spirochetes. Humans and other mammals can be infected with LB organisms for a period of months to years. In experimentally infected C3H/HeN mice, *B. burgdorferi*can be routinely cultured from 2 mm skin biopsies throughout the lifetime of the animal (\~2 years). It is thought that Lyme *Borrelia* utilize several mechanisms to evade the immune response and cause persistent infection; these include antigenic variation, complement cascade inactivation, and invasion of protective niches \[[@R11]\]. In *B. burgdorferi*B31, the VMP-like sequence (*vls*) antigenic variation system is harbored on a 28 kilobase (kb) linear plasmid called lp28-1 \[[@R12]\]. This elaborate system consists of a single expression site (*vlsE*) as well as a contiguous array of 15 silent cassettes (Fig. **3**). These silent cassettes share \>90% sequence identity with the central region of the *vlsE* gene, but have six variable regions that encode different amino acids. During mammalian infection, segments of the *vls* silent cassettes are transferred *via* gene conversion events into the *vlsE* central cassette region. This genetic mechanism results in changes in the amino acid sequence of the encoded surface lipoprotein VlsE, which in turn alters the epitopes present. Thus antibodies directed against previous versions of VlsE will not be effective in eliminating organisms expressing the new variants of VlsE. This process keeps the spirochete one step ahead of the immune response and hence contributes to immune evasion.

Until recently, *vlsE* recombination had only been observed during infection of mammals; it had not been detected in ticks or during *in vitro* culture. This result indicated that some condition present in mammalian tissue (a 'signal') activated the gene conversion process. Diane Edmondson *et al*. (manuscript in preparation) have now shown that *B. burgdorferi*invades and proliferates to high levels in mouse tissue explants, and that *vlsE* recombination events can be detected in the spirochetes present in these explants. The recombination events appear to occur at low frequency, but their detection indicates that at least some of the environmental signals required for the activation of this process are present in this *ex vivo* system. The availability of this model system may permit detailed examination of the mechanisms of *vlsE* recombination and the regulation of this activity.

Structural analysis of Lyme disease *Borrelia* provides another potential avenue for exploring how these spirochetes interact with vertebrate and arthropod hosts. Dr. Jun Liu in our department has begun a series of studies of *B. burgdorferi* and other spirochetes using a technique called cryoelectron tomography (CryoET). CryoET is a form of electron microscopy (EM) in which viable organisms are flash frozen without fixation on EM grids and then imaged at different angles relative to the electron beam. Using Fourier transformation, these images are then averaged to create a three dimensional model of the organisms. These 3D models resemble microscopic CT scans and contain a remarkable amount of structural information. Thus far, CryoET has been utilized to study the inner and outer membranes, peptidoglycan layer, flagellar motor and filament, and chemotaxis receptor structures of *B. burgdorferi* and other organisms (Fig. **[4](#F4){ref-type="fig"}**). Discrete structures such as the flagellar motor and filament and the chemotaxis receptor can be extracted and averaged to form more detailed molecular models of their architecture. Comparison of mutant bacteria lacking one or more proteins with their 'wild type' parent strains provides valuable information about the structural location and hence the functional roles of the proteins under study. This approach has begun to unravel the mechanisms of motility and chemotaxis, both of which are important in the pathogenesis of Lyme borreliosis and many other infectious diseases.

Many mysteries remain with regard to the ability of Lyme *Borrelia* to colonize, proliferate, disseminate, persist, and cause disease in humans and other vertebrate hosts. However, the powerful combination of genetic, molecular, structural, and pathobiologic approaches has begun to 'chip away' at the underlying processes in the infection cycle, and promises to lead to further improvements in Lyme borreliosis diagnosis, treatment, and prevention in the coming years.
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![Similarities of the time course of two invasive, persistent spirochetal infections, Lyme borreliosis and syphilis.](TONEUJ-6-119_F1){#F1}

![An example of signature tagged mutagenesis (STM) analysis of *B. burgdorferi* transposon mutant infectivity. In the experiment shown, C3H/HeN mice were inoculated with 11 different *B. burgdorferi* mutants, each with a different 7 bp 'signature tag'. After 2 and 4 weeks, groups of three mice were euthanized, and five tissues were analyzed for the presence of each mutant using a PCR-based method with Luminex detection of the resulting fluorescent signal, called the Median Fluorescent Intensity (MFI). The genes mutated in each of the clones tested in this experiment is shown on the Y axis. The number at the end of each designation is the insertion ratio, i.e. the distance in bp of the insertion from the 5' end of the gene divided by the full length of the gene. The bars represent the cumulative MFI values for each of the 5 tissues ([B]{.ul}ladder, [E]{.ul}ar, [H]{.ul}eart, [J]{.ul}oint, and [S]{.ul}kin \[inoculation site\]) in the three mice (numbered 1-3). Short bars indicate little or no infectivity, whereas long bars correspond to full infectivity. The first mutant, in the *pncA* (nicotinamidase) gene, is noninfectious in mice and serves as a negative control. The second mutant, in the conserved hypothetical protein gene *BB0051*, has intermediate infectivity.](TONEUJ-6-119_F2){#F2}

![The *vlsE* antigenic variation system of Lyme disease *Borrelia*. The *vls* locus of *B. burgdorferi* B31 (top of figure) consists of the vlsE gene (that encodes the surface lipoprotein VlsE) and a contiguous series of 15 *vls* silent cassettes (that are not expressed). Each of the silent cassettes are highly homologous to the central cassette region of *vlsE*, but encode different amino acids in each of 6 variable regions. During mammalian infection, segments of the silent cassettes replace the corresponding region in the *vlsE* expression site, as shown in the hypothetical example in the lower part of the figure. This process results in *vlsE* sequence variants that have different amino acid sequences and hence different epitopes. *vlsE* recombination occurs continuously during mammalian infection, and contributes to immune evasion and long-term survival of Lyme disease *Borrelia* in humans and other vertebrate hosts. Adapted from Ref. \[[@R13]\].](TONEUJ-6-119_F3){#F3}

![Structure of *B. burgdorferi* B31, as revealed by cryoelectron tomography (CryoET). **A**) Full length view of *B. burgdorferi* B31, as seen by darkfield microscopy. Bar = 1 µm. **B**) One CryoET 'slice' through the three-dimensional model of a *B. burgdorferi* cell, depicting the outer membrane (OM) with outer surface proteins (OSP), peptidoglycan layer (PG), inner membrane (IM), and a flagellar motor and filament. **C**) Closer view of the inset shown in panel B, showing a flagellar motor, the hook structure connecting the motor to the flagellar filament, the lipid bilayer of the OM, and the OSP layer. **D**) a 3D cutaway model of the flagellar motor, produced through the compilation of data from 1280 individual motors. The predicted locations of the rotor, stator, C-ring, and export apparatus are indicated. Adapted from Ref. \[[@R14]\].](TONEUJ-6-119_F4){#F4}
